OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Home » Week of 11/7/22-11/11/22
Credit ratings are not currently available for public cannabis companies leaving companies, lenders and investors with a gap of information. The Viridian Cannabis Credit Tracker fills this gap. The model uses 11 market and financial statement variables to discern 4 key credit factors: Liquidity, Leverage, Profitability, and Size, to provide credit/liquidity analysis for over 370 public Cannabis/Hemp companies.
The Viridian Credit Tracker utilizes 11 different bespoke credit ratios to evaluate four aspects of credit quality: Liquidity, Leverage, Profitability, and Size. We are looking carefully at liquidity, given the challenging environment for capital raises. The median cash flow adjusted current ratio for the 95 Cultivation & Retail companies in our database is only .65x, indicating that more than half of the companies will require financing to make it through the following year. Even the highest 25% of the group is only above 1.48x, not particularly liquid. The SAFE+ Act, if passed, has the potential to revolutionize cannabis liquidity. Cannabis companies now have to maintain balance sheet liquidity because, unlike most American corporations, they have not been able to keep committed but unfunded credit lines as a source of liquidity. We do not expect SAFE to make this difference immediately, but it will be a meaningful start in the right direction.
The Viridian Credit Tracker utilizes 11 different bespoke credit ratios to evaluate four aspects of credit quality: Liquidity, Leverage, Profitability, and Size. We are looking carefully at liquidity, given the challenging environment for capital raises. The median cash flow adjusted current ratio for the 95 Cultivation & Retail companies in our database is only .65x, indicating that more than half of the companies will require financing to make it through the following year. Even the highest 25% of the group is only above 1.48x, not particularly liquid. The SAFE+ Act, if passed, has the potential to revolutionize cannabis liquidity. Cannabis companies now have to maintain balance sheet liquidity because, unlike most American corporations, they have not been able to keep committed but unfunded credit lines as a source of liquidity. We do not expect SAFE to make this difference immediately, but it will be a meaningful start in the right direction.
*Marijuana remains illegal under federal law. The Federal Government does not recognize marijuana to have any medicinal values. Marijuana cultivation, possession, consumption, sales, and distribution are illegal under federal laws and also certain state laws. Please note that there are differences in marijuana laws from one state, county, or city to another.
Copyright Viridian Capital Advisors © 2022